Clinical trial
A Study to Evaluate the Treatment of Previously Untreated B-Cell Chronic…
NCT00302861 · Genitope Corporation, Industry · Terminated
Key facts
| NCT number | NCT00302861 |
|---|---|
| Title | A Study to Evaluate the Treatment of Previously Untreated B-Cell Chronic Lymphocytic Leukemia (B-CLL) |
| Official title | Phase 1/2 Study to Evaluate the Feasibility and Tolerability of Treatment of Previously Untreated B-CLL Chronic Lymphocytic Leukemia (B-CLL) Patients With Recombinant Idiotype Conjugated to KLH (Id-KLH) Administered With GM-CSF |
| Lead sponsor | Genitope Corporation, Industry |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | B-Cell Chronic Lymphocytic Leukemia |
| Intervention type | Biological |
| Interventions | MyVax |
| Enrollment | 86 |
| Start date | Mar 1, 2006 |
| First posted | Mar 15, 2006 |
| Last update posted | Mar 18, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: